Literature DB >> 17635515

Telomere dynamics: the means to an end.

M Matulić1, M Sopta, I Rubelj.   

Abstract

Telomeres are among the most important structures in eukaryotic cells. Creating the physical ends of linear chromosomes, they play a crucial role in maintaining genome stability, control of cell division, cell growth and senescence. In vertebrates, telomeres consist of G-rich repetitive DNA sequences (TTAGGG)n and specific proteins, creating a specialized structure called the telosome that through mutual interactions with many other factors in the cell give rise to dynamic regulation of chromosome maintenance. In this review, we survey the structural and mechanistic aspects of telomere length regulation and how these processes lead to alterations in normal and immortal cell growth.

Mesh:

Substances:

Year:  2007        PMID: 17635515      PMCID: PMC6496270          DOI: 10.1111/j.1365-2184.2007.00452.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  127 in total

1.  DNA damage foci at dysfunctional telomeres.

Authors:  Hiroyuki Takai; Agata Smogorzewska; Titia de Lange
Journal:  Curr Biol       Date:  2003-09-02       Impact factor: 10.834

2.  Cell cycle-dependent recruitment of telomerase RNA and Cajal bodies to human telomeres.

Authors:  Beáta E Jády; Patricia Richard; Edouard Bertrand; Tamás Kiss
Journal:  Mol Biol Cell       Date:  2005-11-30       Impact factor: 4.138

3.  Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops.

Authors:  Anthony J Cesare; Jack D Griffith
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

Review 4.  Mice with bad ends: mouse models for the study of telomeres and telomerase in cancer and aging.

Authors:  María A Blasco
Journal:  EMBO J       Date:  2005-03-10       Impact factor: 11.598

5.  NMR structure of the hRap1 Myb motif reveals a canonical three-helix bundle lacking the positive surface charge typical of Myb DNA-binding domains.

Authors:  S Hanaoka; A Nagadoi; S Yoshimura; S Aimoto; B Li; T de Lange; Y Nishimura
Journal:  J Mol Biol       Date:  2001-09-07       Impact factor: 5.469

Review 6.  Telomere biology: a new player in the end zone.

Authors:  Lorel Colgin; Roger Reddel
Journal:  Curr Biol       Date:  2004-10-26       Impact factor: 10.834

7.  Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a).

Authors:  Utz Herbig; Wendy A Jobling; Benjamin P C Chen; David J Chen; John M Sedivy
Journal:  Mol Cell       Date:  2004-05-21       Impact factor: 17.970

8.  POT1 as a terminal transducer of TRF1 telomere length control.

Authors:  Diego Loayza; Titia De Lange
Journal:  Nature       Date:  2003-05-25       Impact factor: 49.962

9.  Functional subdomain in the ankyrin domain of tankyrase 1 required for poly(ADP-ribosyl)ation of TRF1 and telomere elongation.

Authors:  Hiroyuki Seimiya; Yukiko Muramatsu; Susan Smith; Takashi Tsuruo
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

10.  DNA self-recognition in the structure of Pot1 bound to telomeric single-stranded DNA.

Authors:  Ming Lei; Elaine R Podell; Peter Baumann; Thomas R Cech
Journal:  Nature       Date:  2003-11-13       Impact factor: 49.962

View more
  2 in total

1.  Telomere maintenance in laser capture microdissection-purified Barrett's adenocarcinoma cells and effect of telomerase inhibition in vivo.

Authors:  Masood A Shammas; Aamer Qazi; Ramesh B Batchu; Robert C Bertheau; Jason Y Y Wong; Manjula Y Rao; Madhu Prasad; Diptiman Chanda; Selvarangan Ponnazhagan; Kenneth C Anderson; Christopher P Steffes; Nikhil C Munshi; Immaculata De Vivo; David G Beer; Sergei Gryaznov; Donald W Weaver; Raj K Goyal
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

Review 2.  Biology of telomeres: importance in etiology of esophageal cancer and as therapeutic target.

Authors:  Jagannath Pal; Jason S Gold; Nikhil C Munshi; Masood A Shammas
Journal:  Transl Res       Date:  2013-10-01       Impact factor: 7.012

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.